The Management of Lymphoma in the Setting of Pregnancy

por Pinnix, Chelsea C, Andraos, Therese Y., Milgrom, Sarah, Fanale, Michelle A.
Publicado en Curr Hematol Malig Rep (2017)

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

por Connors, Joseph M., Ansell, Stephen M., Fanale, Michelle, Park, Steven I., Younes, Anas
Publicado en Blood (2017)

Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

por Forero-Torres, Andres, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L., Rosenblatt, Joseph D., Kennedy, Dana A., Younes, Anas
Publicado 2012

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Hagemeister, Fredrick B.
Publicado en Br J Haematol (2016)

Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma

por Pinnix, Chelsea C., Huo, Jinhai, Milgrom, Sarah A., Yehia, Zeinab Abou, Fanale, Michelle, Oki, Yasuhiro, Dabaja, Bouthaina S., Smith, Grace L.
Publicado en Adv Radiat Oncol (2018)

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

por Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
Publicado en Onco Targets Ther (2016)

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Nastoupil, Loretta J., Westin, Jason R., Fayad, Luis E., Neelapu, Sattva S., Cheah, Chan Yoon
Publicado en Oncotarget (2018)

Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement

por Jensen, Garrett L., Dabaja, Bouthaina S., Pinnix, Chelsea C., Gunther, Jillian R., Huen, Auris, Duvic, Madeleine, Oki, Yasuhiro, Fanale, Michelle, Hosing, Chitra, Milgrom, Sarah A.
Publicado en Case Rep Oncol (2018)

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma

por Oki, Yasuhiro, Fanale, Michelle, Romaguera, Jorge, Fayad, Luis, Fowler, Nathan, Copeland, Amanda, Samaniego, Felipe, Kwak, Larry W., Neelapu, Sattva, Wang, Michael, Feng, Lei, Younes, Anas
Publicado en Br J Haematol (2015)

Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach

por Oki, Yasuhiro, Neelapu, Sattva S., Fanale, Michelle, Kwak, Larry W., Fayad, Luis, Rodriguez, Maria A., Wallace, Michael, Klinger, Mark, Carlton, Victoria, Kong, Katherine, Faham, Malek, Younes, Anas
Publicado en Br J Haematol (2015)

TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas

por Weng, Jinsheng, Rawal, Seema, Chu, Fuliang, Park, Hyun Jun, Sharma, Rakesh, Delgado, David A., Fayad, Luis, Fanale, Michelle, Romaguera, Jorge, Luong, Amber, Kwak, Larry W., Neelapu, Sattva S.
Publicado 2012

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

por Chen, Robert, Armand, Phillippe, Fanale, Michelle A, Ribrag, Vincent, Zinzani, Pier Luigi, Ricart, Alejandro D, Thompson, Seth, Balakumaran, Arun, Molin, Daniel, Shipp, Margaret A, Moskowitz, Craig H
Publicado en J Immunother Cancer (2015)

T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment

por Casulo, Carla, O’Connor, Owen, Shustov, Andrei, Fanale, Michelle, Friedberg, Jonathan W., Leonard, John P., Kahl, Brad S., Little, Richard F., Pinter-Brown, Lauren, Advani, Ranjani, Horwitz, Steven
Publicado en J Natl Cancer Inst (2016)

Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30(+) Peripheral T-Cell Lymphomas: Results of a Phase I Study

por Fanale, Michelle A., Horwitz, Steven M., Forero-Torres, Andres, Bartlett, Nancy L., Advani, Ranjana H., Pro, Barbara, Chen, Robert W., Davies, Andrew, Illidge, Tim, Huebner, Dirk, Kennedy, Dana A., Shustov, Andrei R.
Publicado 2014

High-dose chemotherapy and Autologous Stem Cell Transplantation For Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

por Karuturi, Meghan, Hosing, Chitra, Fanale, Michelle, Medeiros, L. Jeffrey, Alousi, Amin M., de Lima, Marcos J., Qazilbash, Muzaffar H., Kebriaei, Partow, Younes, Anas, Khouri, Issa, Andersson, Borje S., Champlin, Richard, Anderlini, Paolo, Popat, Uday
Publicado en Biol Blood Marrow Transplant (2013)

The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma

por Oki, Yasuhiro, Chuang, Hubert, Chasen, Beth, Jessop, Aaron, Pan, Tinsu, Fanale, Michelle, Dabaja, Bouthaina, Fowler, Nathan, Romaguera, Jorge, Fayad, Luis, Hagemeister, Fredrick, Rodriguez, Maria Alma, Neelapu, Sattva, Samaniego, Felipe, Kwak, Larry, Younes, Anas
Publicado en Br J Haematol (2014)

Phase 1 dose-escalation study of anti CTLA-4 antibody ipilimumab and lenalidomide in patients with advanced cancers

por Sakamuri, Divya, Glitza, Isabella C., Betancourt Cuellar, Sonia L., Subbiah, Vivek, Fu, Siqing, Tsimberidou, Apostolia M., Wheler, Jennifer J., Hong, David S., Naing, Aung, Falchook, Gerald S., Fanale, Michelle A., Cabanillas, Maria E., Janku, Filip
Publicado en Mol Cancer Ther (2017)

Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes

por Younes, Anas, Romaguera, Jorge, Fanale, Michelle, McLaughlin, Peter, Hagemeister, Frederick, Copeland, Amanda, Neelapu, Sattva, Kwak, Larry, Shah, Jatin, de Castro Faria, Silvana, Hart, Stefan, Wood, Jeanette, Jayaraman, Ramesh, Ethirajulu, Kantharaj, Zhu, Joy
Publicado en J Clin Oncol (2012)

Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation

por Gunther, Jillian R., Fanale, Michelle A., Reddy, Jay P., Akhtari, Mani, Smith, Grace L., Pinnix, Chelsea C., Milgrom, Sarah A., Yehia, Zeinab Abou, Allen, Pamela K., Osborne, Eleanor M., Mawlawi, Osama, Dabaja, Bouthaina S.
Publicado en Int J Radiat Oncol Biol Phys (2016)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

por Strati, Paolo, Fanale, Michelle A., Oki, Yasuhiro, Turturro, Francesco, Fayad, Luis E, Bartlett, Nancy L., Gladstone, Douglas E., Kasamon, Yvette L., Portlock, Carol S., Wilson, Wyndham H., Goy, Andre, Younes, Anas, Lee, Hun Ju
Publicado en Haematologica (2019)